IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.9600
-0.0750 (-7.25%)
Aug 3, 2026, 3:20 PM EDT - Market open
IN8bio Market Cap
IN8bio has a market cap or net worth of $9.45 million as of August 3, 2026. Its market cap has increased by 30.08% in one year.
Market Cap
9.45M
Enterprise Value
-9.40M
1-Year Change
30.08%
Ranking
Category
Stock Price
$0.96
ChartMarket Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $9.45M, a decrease of -94.96%. That is a compound annual growth rate of -44.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 9.45M | -58.61% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 11.22M |
| Chemomab Therapeutics | 11.16M |
| CytoMed Therapeutics | 11.01M |
| Senti Biosciences Holdings | 10.60M |
| GT Biopharma | 10.58M |
| Exicure | 10.20M |
| Vistagen Therapeutics | 9.89M |
| Curis | 9.78M |